SCHEMBL19494707

SCHEMBL19494707

N#CC1CCN([S+]([O-])c2cc(C(N)=O)c(NC(=O)c3ccccc3F)s2)CC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.40
▸ RAB9A P51151 4/20 0.40
▸ MAPK10 P53779 1/20 0.39
▸ IKBKB O14920 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ GAA P10253 1/20 0.37
▸ LMNA P02545 2/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RORC P51449 2/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16338098 0.79 CFTR (0.48) NPC1RAB9AMAPK10IKBKBKDM4E
SCHEMBL16261720 0.74 RAB9A (0.47) NPC1RAB9AIKBKBKDM4EALDH1A1
SCHEMBL19494428 0.74 RORC (0.42) NPC1RAB9AIKBKBKDM4EALDH1A1
SCHEMBL16263912 0.74 BCL3 (0.42) NPC1RAB9AIKBKBALDH1A1MAPT
SCHEMBL19494729 0.74 NPC1 (0.42) NPC1RAB9AMAPK10IKBKBKDM4E
SCHEMBL19494912 0.74 CFTR (0.40) NPC1RAB9AMAPK10KDM4EALDH1A1
SCHEMBL16263736 0.73 CFTR (0.45) NPC1RAB9AMAPK10IKBKBKDM4E
SCHEMBL16263847 0.73 NPC1 (0.42) NPC1RAB9AMAPK10IKBKBKDM4E
SCHEMBL16263849 0.73 CNR2 (0.42) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL19494315 0.71 NPC1 (0.43) NPC1RAB9AIKBKBKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback